By Josh Beckerman
Dermata Therapeutics Inc. rose 24%, to $3.49, on Thursday after the biotechnology company increased the size of a stock and warrant offering.
The shares hit a high of $4.80 on volume of more than 1.6 million shares, compared with a 65-day average of 99,051.
Dermata…
Read the full article here